Kirby Janine, Halligan Eugene, Baptista Melisa J, Allen Simon, Heath Paul R, Holden Hazel, Barber Sian C, Loynes Catherine A, Wood-Allum Clare A, Lunec Joseph, Shaw Pamela J
Academic Neurology Unit, University of Sheffield, School of Medicine and Biomedical Sciences, Sheffield, UK.
Brain. 2005 Jul;128(Pt 7):1686-706. doi: 10.1093/brain/awh503. Epub 2005 May 4.
Familial amyotrophic lateral sclerosis (FALS) is caused, in 20% of cases, by mutations in the Cu/Zn superoxide dismutase gene (SOD1). Although motor neuron injury occurs through a toxic gain of function, the precise mechanism(s) remains unclear. Using an established NSC34 cellular model for SOD1-associated FALS, we investigated the effects of mutant SOD1 specifically in cells modelling the vulnerable cell population, the motor neurons, without contamination from non-neuronal cells present in CNS. Using gene expression profiling, 268 transcripts were differentially expressed in the presence of mutant human G93A SOD1. Of these, 197 were decreased, demonstrating that the presence of mutant SOD1 leads to a marked degree of transcriptional repression. Amongst these were a group of antioxidant response element (ARE) genes encoding phase II detoxifying enzymes and antioxidant response proteins (so-called 'programmed cell life' genes), the expression of which is regulated by the transcription factor NRF2. We provide evidence that dysregulation of Nrf2 and the ARE, coupled with reduced pentose phosphate pathway activity and decreased generation of NADPH, represent significant and hitherto unrecognized components of the toxic gain of function of mutant SOD1. Other genes of interest significantly altered in the presence of mutant SOD1 include several previously implicated in neurodegeneration, as well as genes involved in protein degradation, the immune response, cell death/survival and the heat shock response. Preliminary studies on isolated motor neurons from SOD1-associated motor neuron disease cases suggest key genes are also differently expressed in the human disease.
20%的家族性肌萎缩侧索硬化症(FALS)由铜/锌超氧化物歧化酶基因(SOD1)突变引起。尽管运动神经元损伤是通过功能毒性获得发生的,但其确切机制仍不清楚。我们使用已建立的与SOD1相关的FALS的NSC34细胞模型,专门研究了突变型SOD1在模拟易损细胞群体即运动神经元的细胞中的作用,而不受中枢神经系统中非神经元细胞的污染。通过基因表达谱分析,在存在突变型人类G93A SOD1的情况下,有268个转录本差异表达。其中,197个表达降低,表明突变型SOD1的存在导致显著程度的转录抑制。其中包括一组编码II期解毒酶和抗氧化反应蛋白的抗氧化反应元件(ARE)基因(即所谓的“程序性细胞存活”基因),其表达受转录因子NRF2调控。我们提供的证据表明,Nrf2和ARE的失调,再加上磷酸戊糖途径活性降低和NADPH生成减少,是突变型SOD1功能毒性获得的重要且迄今未被认识的组成部分。在存在突变型SOD1的情况下显著改变的其他感兴趣的基因包括几个先前与神经退行性变有关的基因,以及参与蛋白质降解、免疫反应、细胞死亡/存活和热休克反应的基因。对来自与SOD1相关的运动神经元疾病病例的分离运动神经元的初步研究表明,关键基因在人类疾病中也有不同表达。